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Though skin is protective shield of body still it is prone to not only wounds, burns but also to microbial invasion 
which may be mainly due to bacteria, fungi or various strains of viruses. Frequently reported dermal ailments 
are acne, measles, psoriasis, impetigo, cellulitis, molluscum contagiosum, tinea capitis, tinea pedis, atopic 
dermatitis, chronic wounds, ring worm, scabies, and onychomycosis which have broad spectrum 
pathophysiological effects. There are several root causes of the onset of development of infectious skin 
microbiota but major ones are intake of improper diet and lack of personal hygiene awareness and practice. To 
control these skin microbial diseases further research is required to find out low cost healthy food alternatives 
and programmed public awareness related to personal hygiene.        
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1. Introduction  
Skin is a unique form of connective tissue which not only covers the body surface but also performs thermal and 
homeostatic regulations by providing a variety of microenvironments e.g., variation in UV contact, pH, 
moisture, sebum content and topography. But its broad spectrum functioning may disturb due to various factors 
like skin burns, cuts, growing age and many other dermal ailments [1, 2, 8, 10]. The skin texture may be of 
different types like sebaceous, moisture having and dry because it is influenced by activity of sweat and 
sebaceous glands and by growth of hair follicles. As sweat glands are thermoregulatory in nature which are 
connected to the hair follicles localized in oily sites, biochemically the secretion of sebaceous glands is lipid-
rich sebum so serve as a hydrophobic, lubricating and antibacterial shield [2, 3].  
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But still there is risk of  microbial invasion. The potent sources of microbial invasion may be either of bacterial, 
fungal or viral origin even sometimes algal too [4]. Moreover, in daily life another potent source of microbial 
exposure to skin is via various animals and their meat handling either in farms or at slaughter houses [6, 7]. 
These microbial dermal infections may become severe and can be converted into oncogenic disorders [9]. 
2. Microbial dermal ailments 
Following are the commonly reported types of microbial skin diseases which occur either due to intake of 
infected diet or microbial exposure through other routes (Table.1): 
Table 1: Major skin microbial diseases and their pathophysiology 
Skin Disease Causative agent Pathophysiology Reference(s) 
 
Acne 





Severe inflammation and deep scars 
 






Severe systemic viral disorder of 
approximately 9–19 days duration which 
initiates fever and malaise then cough, coryza 















A chronic form of dermal thickening and 





Impetigo Staphylococcus aureus  
Streptococcus pyogenes 




  Cellulitis 
S. pyogenes 
S. aureus 
Acute inflammation usually results from 
bacterial exposure via various skin wounds and 






Molluscipox Dermal lesion mainly on the palms and around 






A commonly reported fungal infection of the 
scalp, hair shaft and hair follicles which often 
results in patchy hair loss, scaling and serious 





Trichophyton rubrum  
T. interdigitale  
Epidermophyton  floccosum 
An inflammatory and ulcerative infection of 
feet which occurs not only on soles of feet but 





S. aureus Inflammation associated with severe rashes 









Various fungal, protozoan and 
viral strains  
Usually lasts for more than three months with 
prolonged severe inflammation, persistent 









Trichophyton mentagrophytes  
T. rubrum  
Microsporum canis 
Candida albicans 
This infection usually spreads on nail bed, 
scalp and skin due to exposure of already 
infected items e.g., clothing, utensils, furniture 
and even via pets etc. The characteristic 
features of its pathology are the occurrence of 
gradually growing diameter reddish circular 





S. aureus  
S. pyogenes 
Dermal itching which may convert into diverse 
severe forms like cellulitis abscesses, 
necrotizing fasciitis or it may result into renal 








Frequently reported fungal infection of nails 
which may occur on superficial, distal, lateral 
and proximal subungual sides and also in 
candidal form.  
 
[5] 
3. Control of microbial dermal disorders  
Following preventive measures should be adapted to control commonly occurring skin microbial diseases 
(Figure 1): 






Figure 1: Control of Microbial skin diseases 
4. Conclusion   
Lack of general public awareness about personal hygiene is a major global problem especially of developing 
countries. Another factor is economic crisis as an outcome huge population has poor living standards and is 
more prone to skin infectious microbiota due to intake of improper and unhealthy diet, untidy living 
environment and inability to avail proper dermal treatment due to financial constraints. To control such skin 
disorders of microbial origin suitable remedies either apitherapy based, herbal or synthetic antibiotics should be 
utilized [4, 5, 90]. Moreover, personal hygiene based general public awareness programs should be introduced at 
national and international levels.  
 
Protect your skin from exposure 
of dust and pollutants 
Protect your skin from acute 
thermal & UV exposures 
On exposure of skin microbes, take 
proper antibiotics, herbal & 
apitherapy based remedies 
Requirement of general public 
awareness related to healthy diet 
intake and personal hygiene 
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5. Future perspective  
Future researchers should introduce better ideas of low cost alternatives of junk and staple food for common 
man at global level. Similarly, formation of side effects free skin care and dermal ailments’ recovery products 
are also required, in this regard publicity of natural produce based items either of herbal, apiculture or other 
animals based which should also be ethically allowed, is need of current era. All such efforts will be more 
effective, if they are monitored and delivered globally to general public via electronic media which is currently 
accessible at individual level.    
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